These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21041283)

  • 1. Elevated fibroblast growth factor 23 levels in a newborn with secondary hypoparathyroidism.
    Bech A; Nabbe K; Brussel W; Telting D; de Boer H
    Pediatrics; 2010 Dec; 126(6):e1613-6. PubMed ID: 21041283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
    Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism.
    Kazama JJ; Gejyo F; Shigematsu T; Fukagawa M
    Ther Apher Dial; 2005 Aug; 9(4):328-30. PubMed ID: 16076376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice.
    Tsuji K; Maeda T; Kawane T; Matsunuma A; Horiuchi N
    J Bone Miner Res; 2010 Aug; 25(8):1711-23. PubMed ID: 20200981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients.
    Fassbender WJ; Brandenburg V; Schmitz S; Sandig D; Simon SA; Windolf J; Stumpf UC
    Clin Lab; 2009; 55(3-4):144-52. PubMed ID: 19462937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels and dynamic changes of serum fibroblast growth factor 23 in hypophosphatemic rickets/osteomalacia.
    Xia WB; Jiang Y; Li M; Xing XP; Wang O; Hu YY; Zhang HB; Liu HC; Meng XW; Zhou XY
    Chin Med J (Engl); 2010 May; 123(9):1158-62. PubMed ID: 20529556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women.
    Burnett SM; Gunawardene SC; Bringhurst FR; Jüppner H; Lee H; Finkelstein JS
    J Bone Miner Res; 2006 Aug; 21(8):1187-96. PubMed ID: 16869716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine regulation of calcium homeostasis during pregnancy.
    Pitkin RM
    Clin Perinatol; 1983 Oct; 10(3):575-92. PubMed ID: 6360469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.
    Kawata T; Imanishi Y; Kobayashi K; Miki T; Arnold A; Inaba M; Nishizawa Y
    J Am Soc Nephrol; 2007 Oct; 18(10):2683-8. PubMed ID: 17855636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.
    Yamamoto T; Imanishi Y; Kinoshita E; Nakagomi Y; Shimizu N; Miyauchi A; Satomura K; Koshiyama H; Inaba M; Nishizawa Y; Jüppner H; Ozono K
    J Bone Miner Metab; 2005; 23(3):231-7. PubMed ID: 15838626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.
    Shimada T; Hasegawa H; Yamazaki Y; Muto T; Hino R; Takeuchi Y; Fujita T; Nakahara K; Fukumoto S; Yamashita T
    J Bone Miner Res; 2004 Mar; 19(3):429-35. PubMed ID: 15040831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
    Imanishi Y; Kobayashi K; Kawata T; Inaba M; Nishizawa Y
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S32-7. PubMed ID: 17976083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal basic fibroblast growth factor serum levels are associated with pregnancy-induced hypertension.
    Kurz C; Hefler L; Zeisler H; Schatten C; Husslein P; Tempfer C
    J Soc Gynecol Investig; 2001; 8(1):24-6. PubMed ID: 11223353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.